SHENGTAI PHARMACEUTICAL, INC. Operating Income
SHENGTAI PHARMACEUTICAL, INC. reported Operating Income of $1.49 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-05-15
- SHENGTAI PHARMACEUTICAL, INC. operating income (loss) for the quarter ending 2013-03-31 was $1.49M, a 29.55% decline year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. operating income (loss) for the quarter ending 2012-12-31 was $2.09M, a 105.99% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. operating income (loss) for the quarter ending 2012-09-30 was $1.77M, a 43.48% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. operating income (loss) for the quarter ending 2012-06-30 was $1.14M, a 46.89% decline year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. operating income (loss) for fiscal 2012 was $5.50M, a 58.71% decline from fiscal 2011.
- SHENGTAI PHARMACEUTICAL, INC. operating income (loss) for fiscal 2011 was $13.32M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $1.49M 10-Q · filed 2013-05-15 | $3.58M derived: sum of 2 quarters · filed 2013-05-15 | $5.35M 10-Q · filed 2013-05-15 | $6.49M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-12-31 | $2.09M 10-Q · filed 2013-02-14 | $3.86M 10-Q · filed 2013-02-14 | $5.00M derived: sum of 3 quarters · filed 2013-02-14 | $7.11M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-09-30 | $1.77M 10-Q · filed 2012-11-14 | $2.91M derived: sum of 2 quarters · filed 2012-11-14 | $5.02M derived: sum of 3 quarters · filed 2013-05-15 | $6.03M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-06-30 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | $3.25M derived: sum of 2 quarters · filed 2013-05-15 | $4.27M derived: sum of 3 quarters · filed 2013-05-15 | $5.50M 10-K · filed 2012-09-28 |
| 2012-03-31 | $2.11M 10-Q · filed 2013-05-15 | $3.13M derived: sum of 2 quarters · filed 2013-05-15 | $4.36M 10-Q · filed 2013-05-15 | $6.51M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $1.01M 10-Q · filed 2013-02-14 | $2.25M 10-Q · filed 2013-02-14 | $4.39M derived: sum of 3 quarters · filed 2013-02-14 | $8.33M derived: sum of 4 quarters · filed 2013-02-14 |
| 2011-09-30 | $1.23M 10-Q · filed 2012-11-14 | $3.38M derived: sum of 2 quarters · filed 2012-11-14 | $7.32M derived: sum of 3 quarters · filed 2012-11-14 | $11.11M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | $6.08M derived: sum of 2 quarters · filed 2012-09-28 | $9.88M derived: sum of 3 quarters · filed 2012-09-28 | $13.32M 10-K · filed 2012-09-28 |
| 2011-03-31 | $3.94M 10-Q · filed 2012-05-15 | $7.73M derived: sum of 2 quarters · filed 2012-05-15 | $11.17M 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $3.80M 10-Q · filed 2012-02-14 | $7.24M 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | $3.44M 10-Q · filed 2011-11-14 |